Blinatumomab Nonresponse Is Associated with Poor CD19-CAR Outcome in B-ALL

Authors:

Published: 2021-12-03

DOI: 10.1158/2159-8290.cd-rw2021-172

Source: Full article

---

Abstract

Abstract